Clin2
NCT07687056Likely a fitNot yet recruiting

Stroke treatment study for adults

Stroke, Acute IschemicEndovascular ThrombectomyAcute Ischemic Stroke AIS

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a treatment for stroke given soon after symptoms start. It aims to improve recovery by using a medication to dissolve blood clots.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,500 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with a stroke by a doctor.
  • You are able to receive treatment shortly after stroke symptoms begin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06320431Recruiting· Phase 3
Clot-busting drug for disabling stroke within 4.5 hours

This trial tests a clot-busting drug called tenecteplase for people having a disabling ischemic stroke (a clot blocking blood flow to the brain). It aims to see if the drug can help improve recovery when given within 4.5 hours of symptoms starting.

Sydney, Barangaroo
NCT07740018Recruiting
Stroke treatment study for blocked brain arteries

This study looks at how well a procedure to remove blood clots from blocked brain arteries works for people who have had a stroke. It aims to see what factors help people recover better, which could help guide treatment decisions.

Sohag
NCT07727395Recruiting· Phase 3
Clot-busting drug after successful clot removal for stroke

This trial tests whether giving a clot-busting drug (alteplase) directly into the brain artery after a successful clot removal improves recovery in people with severe stroke. It is for patients who have had a thrombectomy and still have a large blocked artery in the front of the brain.

An Giang
NCT06352632Recruiting· Phase 3
Adaptive Stroke Trial Testing New Treatments

This trial is testing different treatments for stroke patients to find which work best. It's designed to adapt over time so new treatments can be added as research progresses.

Sydney, New South Wales
NCT07357987Recruiting· Phase 3
Stroke treatment with tenecteplase via artery

This trial tests a clot-busting drug called tenecteplase given directly into the brain artery for people having a moderate stroke caused by a blockage in a medium-sized blood vessel. The goal is to see if it helps improve recovery when given within 24 hours of stroke symptoms starting.

Beijing, Beijing Municipality
NCT06949228Recruiting· Phase 2/Phase 3
Intra-Arterial Tenecteplase After Clot Removal for Stroke

This trial tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after a successful mechanical clot removal can improve recovery for people with a certain type of stroke. The goal is to see if it safely helps clear any remaining tiny clots and reduces disability.

Toledo, Ohio

Hear when a new Endovascular Thrombectomy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.